CM Hospitalar S/A

BVMF-VVEO3
Brazil Stock Exchange
Healthcare Medical Distribution
Global Rank
#32598
Country Rank
#272
Market Cap
41.54 M
Price
0.132
Change (%)
5.56%
Volume
846,000

CM Hospitalar S/A's latest marketcap:

41.54 M

As of 08/31/2026, CM Hospitalar S/A's market capitalization has reached $41.54 M. According to our data, CM Hospitalar S/A is the 32598th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 41.54 M
Revenue (ttm) 2.27 B
Net Income (ttm) 11 M
Shares Out 315.81 M
EPS (ttm) 0.03
Forward PE 9.54
Ex-Dividend Date 05/02/2024
Earnings Date 08/11/2026
Market Cap Chart
Data Updated: 08/31/2026

CM Hospitalar S/A's yearly market capitalization.

CM Hospitalar S/A has seen its market value drop from R$5.4 B to R$214.75 M since 2021, representing a total decrease of 96.02% and an annual compound decline rate (CAGR) of 49.87%.
Date Market Cap(R$) Market Cap(USD) Change (%) Global Rank
08/31/2026 R$214.75 M $41.54 M -9.86% 32598
12/30/2025 R$448.45 M $83.71 M -30.73% 26536
12/30/2024 R$647.41 M $104.36 M -85.5% 22978
12/28/2023 R$4.46 B $917.93 M -2.31% 9137
12/29/2022 R$4.57 B $860.61 M -15.35% 9050
12/30/2021 R$5.4 B $964.83 M 9537

Company Profile

About CM Hospitalar S/A

CM Hospitalar S/A is a leading distributor of hospital materials, medicines, and nutrition products in Brazil. Founded in 2010 and headquartered in Ribeirão Preto, the company serves healthcare providers with a comprehensive range of medical and pharmaceutical solutions.

Product Offerings

  • Medicines & Therapeutic Solutions: Ophthalmic agents, painkillers, anesthetics, antihypertensives, antibiotics, anticoagulants, antidepressants, antidiabetics, antivirals, and more.
  • Specialized Treatments: Anti-inflammatory, anti-TNF, antineoplastics, immunosuppressants, hormone therapies, and growth factors.
  • Medical Supplies: Orthopedic materials, compression socks, diapers, wipes, and wet towels.
  • Logistics & Support: Medical cargo transportation, pharmaceutical monitoring, and home patient assistance.

Key Services

  • Distribution of hospital and pharmaceutical products.
  • Infrastructure support for healthcare facilities.
  • Specialized patient care services, including home monitoring.

With a commitment to quality and efficiency, CM Hospitalar S/A plays a vital role in Brazil's healthcare supply chain.

Frequently Asked Questions

  • What is CM Hospitalar S/A's (BVMF-VVEO3) current market cap?
    As of 08/31/2026, CM Hospitalar S/A (including the parent company, if applicable) has an estimated market capitalization of $41.54 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • CM Hospitalar S/A global market capitalization ranking is approximately 32598 as of 08/31/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Research Tools

Copyright © 2026. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.